New Treatment for MS Approved

A new treatment has been approved to treat relapsing forms of multiple sclerosis (MS) in adults. The oral treatment, Mavenclad, is approved for treating relapsing-remitting forms of the illness as well as active secondary progressive disease. The federal Food and Drug Administration (FDA), which approved Mavenclad, said that it is not recommended for MS patients… Continue reading New Treatment for MS Approved

Navigating The Health-Care System with MS

At the best of times, today’s healthcare system can seem like a confusing maze. With the added pressures of living with a chronic, unpredictable disease like multiple sclerosis (MS), accessing high quality, comprehensive care can feel even more challenging. The best place to start is with a clear understanding of diseases like MS, and the… Continue reading Navigating The Health-Care System with MS

New Hope in the Fight Against Multiple Sclerosis

Researchers from the University of Maryland Fischell Department of Bioengineering and the University of Maryland School of Medicine report a new way to “turn off” the harmful immune attack that occurs during autoimmune diseases such as multiple sclerosis (MS), while keeping healthy functions of the immune system intact. A release from the university quotes said… Continue reading New Hope in the Fight Against Multiple Sclerosis

Can Fasting Improve your MS Symptoms?

Evidence is increasingly showing that a diet mimicking the effects of fasting has health benefits beyond weight loss, with a new study indicating that it may reduce symptoms of multiple sclerosis. The research was led by experts from the University of Southern California. Scientists discovered that the diet triggers a death-and-life process for cells that… Continue reading Can Fasting Improve your MS Symptoms?

Melatonin and MS

The hormone melatonin, which helps regulates the sleep-wake cycle, may be the reason that multiple sclerosis symptoms improve during the shorter days of winter. A group led by Francisco Quintana, PhD, at the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital (BWH) have found an explanation that could lead to a deeper… Continue reading Melatonin and MS

Chemical Compound Decreases Effects of Multiple Sclerosis

A team of researchers led by biomedical scientist Seema K. Tiwari-Woodruff, an associate professor at the University of California, Riverside School of Medicine has identified a drug called indazole chloride (Ind-Cl) that could stimulate “remyelination,” the re-sheathing of the axons, restoring fast and uninterrupted flow of nerve impulses for patients with multiple sclerosis (MS). This… Continue reading Chemical Compound Decreases Effects of Multiple Sclerosis

Wii Balance Board Helps MS patients

The Nintendo Wii Balance Board video game console can help people with multiple sclerosis (MS) reduce their risk of accidental falls, according to research done at Sapienza University in Rome and published online August 26th 2014 in the journal Radiology. Magnetic resonance imaging (MRI) scans showed that use of the balance board system appears to induce favorable changes in brain connections associated with balance and movement.

Cell Therapy for Multiple Sclerosis

Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient’s own cells.

Mice With MS Walk Again After Stem Cell Tx

Mice severely disabled by a condition similar to multiple sclerosis (MS) could walk less than two weeks following treatment with human stem cells. The study, which uncovers new avenues for treating MS, was don e at the University of Utah and published online on May 15th 2014, in the journal Stem Cell Reports.

A Better Tool for Tracking MS

Imaging scientists at Western University’s Robarts Research Institute in London and Canada have developed a better way to track the progression of Multiple Sclerosis (MS) from its earliest stages. Led by Ravi Menon, PhD, the researchers used what’s called “Quantitative Susceptibility (QS) Magnetic Resonance Imaging (MRI),” to measure damage in specific areas of the brain which the study showed to be common to all patients. The findings were published in advance online in May 2014 in Radiology.

“Energy Source” Implicated in Dementia

Researchers now know that a specific energy source is crucial to cells that maintain cognitive function. That discovery could lead to a better understanding of the cognitive decline in illnesses such as Alzheimer’s and multiple sclerosis.

The source, NAD (nicotinamide adenine dinucleotide), is a molecule that harvests energy from nutrients in food and converts into a usable form for cells.

Antioxidant Drug Knocks Down MS

Researchers led by P. Hemachandra Reddy, Ph.D. at Oregon Health & Science University have discovered that an antioxidant designed by scientists more than a dozen years ago to fight damage within human cells significantly helps symptoms in mice that have a multiple sclerosis-like disease. The study was published in the December 2013 edition of the journal Biochimica et Biophysica Acta Molecular Basis of Disease.